TB500 5mg

5mg vial of TB500

TB-500 is a peptide fragment hormone that is primarily used in the treatment of various muscle injuries or pain caused by inflammation. There is very little official human data available for this product; however, it has been a longtime hormone used in racehorses. TB-500, although synthetic, serves to act as a synthetic form (loosely) of Thymosin Beta-4 (TB-4). TB-500 is not TB-4; although very commonly confused as TB-4, it is designed to provide the benefits of the naturally occurring thymus produced hormone.

In the world of performance enhancement, TB-500 is not meant to be used to bulk, cut, lose fat or increase strength. This is a peptide hormone that is designed to promote healing, specifically the healing of wounded or injured areas of the body. TB-500 can be used to treat muscle tears or strain, tendon inflammation and even skin injuries. This peptide will not cause instant healing of an injured area. If a muscle is torn it is torn, but use of TB-500 will in many cases speed up the healing process. For nagging injuries, those that don’t keep the individual out of the gym but slow his progress, it may provide the edge he needs to continue his training without it being diminished.
The effects of TB-500 have also been linked to hair growth, specifically the reversal of hair loss caused by male-pattern baldness. However, how significant this effect is and how much truth it holds scientifically is still highly questionable as no official data exist. The only data on hair growth is anecdotal.

TB-500 Administration
TB-500 comes in freeze-dried (lyophilized) form and must be reconstituted with bacteriostatic water for administration. The most common dosing range in human use is 2.0 to 2.5mg of TB-500 two times per week for approximately 4-6 weeks. Once the 4-6 weeks of use is complete, once the injured area has improved, some users will reduce to one to two injections per month for injury prevention. Many users report greater muscle flexibility when using TB-500, thereby reducing further injury potential.
Higher doses of TB-500, those beyond 2.0-2.5mg twice per week, there is no data available to support how much stronger such dosing plans will be. There is very little data to support the lower doses beyond anecdotal but even less when it comes to higher doses. As healing and injury prevention is the primary point of use and the 2.0-2.5mg plans seem to carry a high rate of success, this does tend to lend to higher doses being unnecessary.